Archived Newsletters
-
08.11.26 -- Unlocking Global Growth Through Strategic CDMO Partnerships
8/11/2026
08/11/26 Outsourced Pharma Newsletter
-
08.10.26 -- From Cell Therapy To Oral Biologics: Trends Shaping Development
8/10/2026
08/10/26 Outsourced Pharma Newsletter
-
08.10.26 -- Mission-Driven Professionals And Students Build America's Supply Chains
8/10/2026
08/10/26 Outsourced Pharma Newsletter
-
08.08.26 -- Outsourced Pharma Newsletter - Best Of July
8/8/2026
08/08/26 Outsourced Pharma Newsletter
-
08.07.26 -- New Approaches To Accelerate Biologics Development
8/7/2026
08/07/26 Outsourced Pharma Newsletter
-
08.07.26 -- New Podcast Episodes: BoB@BIO, In Vivo Gene Editing, Multispecific Manufacturability, and More
8/7/2026
08/07/26 Outsourced Pharma Newsletter
-
08.07.26 -- Global Ties, Good Fortune Bind Biotech And CDMO
8/7/2026
08/07/26 Outsourced Pharma Newsletter
-
08.06.26 -- As In Vivo Therapies Scale, Vector Supply Becomes Critical
8/6/2026
08/06/26 Outsourced Pharma Newsletter
-
08.06.26 -- Bridging The Gap Between Vaccine Platforms And CDMO Economics
8/6/2026
08/06/26 Outsourced Pharma Newsletter
-
08.05.26 -- Global Ties, Good Fortune Bind Biotech And CDMO
8/5/2026
08/05/26 Outsourced Pharma Newsletter